On July 1, 2020, there will be several changes to the National Immunisation Program (NIP):

Eligibility for free NIP pneumococcal vaccines (Prevenar 13®, Pneumovax 23®)

  • Ceasing Pneumovax 23® for healthy non-Indigenous adults at 65 years of age
  • Commencing Prevenar 13® for healthy non-Indigenous adults ≥70 years of age
  • Commencing Prevenar 13® for Indigenous adults at ≥50 years of age plus Pneumovax 23® x 2 doses in a lifetime
  • Commencing Prevenar 13® for >12 months of age (including adolescents and adults) with newly diagnosed risk conditions plus Pneumovax 23® x 2 doses in a lifetime
  • New eligibility criteria for risk conditions

Eligibility for free NIP meningococcal B (Bexsero®) vaccine:

  • Aboriginal and Torres Strait Islander infants receive 2 primary doses of Bexsero® and 1 booster dose – 2, 4 and 12 months of age
  • Bexsero® catch-up is available for all Aboriginal and Torres Strait Islander children <2 years of age for 3 years until 30 June 2023
  • Some people with risk conditions will be eligible for Bexsero®

Read more about the changes here:

Clinical update: National Immunisation Program (NIP) schedule changes from 1 July 2020 – advice for vaccination providers

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Share This